If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,176.00
Bid: 1,170.00
Ask: 1,185.00
Change: 0.00 (0.00%)
Spread: 15.00 (1.282%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,176.00
BUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Burford sees successful end to Teinver annulment

30 May 2019 07:00

RNS Number : 5798A
Burford Capital Limited
30 May 2019
 

 

This announcement contains inside information.

 

30 May 2019

 

BURFORD CAPITAL ANNOUNCES SUCCESSFUL CONCLUSION TO TEINVER ANNULMENT APPLICATION

 

Burford Capital Limited ("Burford Capital" or "Burford" or "the Company"), the leading global finance and investment management firm focused on law, announced today that the World Bank arbitration panel considering the Republic of Argentina's annulment application in the Teinver matter unanimously dismissed the application and upheld the original tribunal's decision in full.

 

As previously reported, Burford sold its entire interest in the Teinver matter for $107 million in 2018. The transaction included the ability of the purchasers to put the investment back to Burford should annulment be granted whereupon Burford would have had to return $100 million of the purchase price (and Burford would have regained the investment to relitigate the matter). With the decision on annulment, the put has now expired.

 

Burford previously recognised $87 million of income associated with the Teinver sale ($100 million of the sale price less Burford's $13 million investment) and treated the incremental $7 million as the premium for the put, which was then carried at fair value on Burford's balance sheet. With the put now expiring, the $7 million will be recognised as income in Burford's financial results for the six-month period ending 30 June 2019.

 

Now that this investment has concluded, Burford is able to provide a valuation history for the matter, which illustrates Burford's longstanding and conservative valuation process. At the end of 2016, at a point when the arbitral tribunal had decided the key question of jurisdiction in Teinver's favour but had not decided the merits of the case, the investment was carried at a fair value of $30 million, $17 million of which was recognised as an unrealised gain (19% of the ultimate total profit) and $13 million of which was cost. During 2017, the arbitral tribunal decided the entire matter in Teinver's favour and awarded it substantial damages, and Burford increased the investment's fair value by $39 million to $69 million, generating $39 million of unrealised gain and bringing the total amount of unrealised gain to $56 million (60% of the ultimate profit). In 2018, when Burford sold the investment, it recognised a further $31 million of income to bring the matter to $100 million of proceeds and an $87 million realised gain. Now, in 2019, Burford will recognise the final $7 million of income associated with the put's expiration.

 

In aggregate, the Teinver investment produced $107 million of proceeds on a $13 million investment for a total profit of $94 million, a 722% return on invested capital and a 39% IRR.

 

The person responsible for arranging for the release of this announcement on behalf of the Company is Elizabeth O'Connell, Chief Financial Officer.

 

 

For further information, please contact:

 

Burford Capital Limited

Elizabeth O'Connell, CFA, Chief Financial Officer

+1 212 235 6825

Macquarie Capital (Europe) Limited - NOMAD and Joint Broker

+44 (0)20 3037 2000

Jonny Allison

Nicholas Harland

Liberum Capital Limited - Joint Broker

+44 (0)20 3100 2222

Richard Crawley

Jamie Richards

Numis Securities Limited - Joint Broker

+44 (0)20 7260 1000

Charlie Farquhar

Jonathan Abbott

Montfort Communications Limited - Financial Communications

+44 (0)20 3770 7908

Robert Bailhache - email

 

 

About Burford Capital

Burford Capital is the leading global finance and investment management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the London Stock Exchange, and it works with law firms and clients around the world from its principal offices in New York, London, Chicago, Washington, Singapore and Sydney.

 

For more information about Burford: www.burfordcapital.com

 

 

This release does not constitute an offer of any Burford fund.  Burford Capital Investment Management LLC ("BCIM"), which acts as the fund manager of all Burford funds, is registered as an investment adviser with the U.S. Securities and Exchange Commission. The information provided herein is for informational purposes only. Past performance is not indicative of future results. The information contained herein is not, and should not be construed as, an offer to sell or the solicitation of an offer to buy any securities (including, without limitation, interests or shares in the funds). Any such offer or solicitation may be made only by means of a final confidential Private Placement Memorandum and other offering documents.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PFUKMGFKKGFGLZG
Date   Source Headline
13th May 202412:00 pmRNS1Q24 Results & Quarterly Report
9th May 20247:00 amRNSNotice of 1Q24 Results & Results Call Details
16th Apr 20243:30 pmRNSHolding(s) in Company
10th Apr 202412:00 pmRNSNotice of Retail Shareholder Call on June 20, 2024
10th Apr 202412:00 pmRNSIssuance of New Shares in Connection With LTIP
10th Apr 202412:00 pmRNSNotice of 2024 AGM
3rd Apr 20244:30 pmRNSDirector/PDMR Shareholdings & Ownership Update
28th Mar 202411:00 amRNSAvailability of 2023 Annual Report
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20244:45 pmRNSNotification of Transactions by PDMRs
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20244:00 pmRNSIntended Purchases of Ordinary Shares
14th Mar 202411:00 amRNSAnnual results for year ended December 31, 2023
7th Mar 20245:30 pmRNSHolding(s) in Company
7th Mar 20242:00 pmRNSNotice of 2023 Results & Results Call Details
30th Jan 20244:15 pmRNSClosing of Private Offering of Senior Notes
18th Jan 202412:00 pmRNSPamela Corrie Appointed as Board Director
17th Jan 20247:00 amRNSPricing and Upsizing of Senior Notes Offering
16th Jan 202412:45 pmRNSPrivate Offering of Senior Notes
3rd Jan 202412:00 pmRNSIssuance of New Shares in Connection with LTIP
22nd Nov 202312:00 pmRNSDirector/PDMR Shareholding
16th Nov 202312:00 pmRNSSterling Conversion Rate for 2023 Interim Dividend
9th Nov 202312:00 pmRNS3Q23 Results & Quarterly Report
3rd Nov 20237:05 amRNSNotice of 3Q23 Results & Results Call Details
9th Oct 202312:00 pmRNSIssuance of New Shares in Connection with LTIP
9th Oct 202311:45 amRNSExpansion and Further Extension of SWF Arrangement
27th Sep 20235:30 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSTransaction in Own Shares
25th Sep 20237:00 amRNSTransaction in Own Shares
22nd Sep 20237:00 amRNSTransaction in Own Shares
21st Sep 20237:00 amRNSTransaction in Own Shares
19th Sep 20231:30 pmRNSTransaction in Own Shares
13th Sep 202312:00 pmRNS2Q23 Results & Quarterly Report
11th Sep 20237:00 amRNSStatement on YPF Damages Ruling
8th Sep 20234:30 pmRNSSuspension - Burford Capital Limited
8th Sep 20234:09 pmRNSStatement re Petersen and Eton Park Matters
31st Aug 20232:00 pmRNSNotice of 2Q23 Results Call Details
25th Aug 20237:00 amRNSUS SEC Closes Comment Letter Review
9th Aug 20232:00 pmRNSDirector/PDMR Shareholding
12th Jul 202310:37 amRNSResult of AGM
7th Jul 202312:45 pmRNSPricing of Early Redemption of 2024 Bonds
4th Jul 20235:00 pmRNSTransaction in Own Shares
3rd Jul 20232:00 pmRNSCompletion of Share Purchases & PDMR Transactions
29th Jun 202311:14 amRNSIntended Purchases of Ordinary Shares
26th Jun 20236:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.